topic:stem_cell_treatments - Google News: Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen - The Herald | HeraldOnline.com

0 Comments
topic:stem_cell_treatments - Google News
Google News
Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen - The Herald | HeraldOnline.com
Sep 28th 2012, 04:12


Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen
The Herald | HeraldOnline.com
Prochymal (remestemcel-L) is a first-in-class mesenchymal stem cell therapy indicated for the treatment of acute graft-vs-host disease (GvHD) in children. In May, Prochymal became the world's first stem cell therapy to be approved by an internationally ...

and more »
You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions


About Post Author

Morbi leo risus, porta ac consectetur ac, vestibulum at eros. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus.

You may also like

Tidak ada komentar:

About

Facebook